USPTO serial 79292101
ONCOCOLLAPSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 11, 2021
- Examiner
- CIANCI, RYAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ONCOCOLLAPSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Clifford D Hyra
Clifford D Hyra FRESH IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical drugs based on peptides for treating oncological diseases; peptides as drugs to induce protein aggregation for treating oncological diseases; peptides as drugs to induce protein aggregation resulting in proteostatic collapse for treating oncological diseases | ACTIVE | — |
| 042 | Medical and pharmaceutical research services; pharmaceutical research and development of pharmaceutical products and drugs based on peptides; pharmaceutical research and development of pharmaceutical products and drugs based on protein aggregation stimulating peptides; pharmaceutical research and development of pharmaceutical products and drugs based on aggregation stimulating peptides leading to proteostatic collapse | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AELIN THERAPEUTICS
- Other trademarks owned by AELIN THERAPEUTICS
- Other trademarks owned by AELIN THERAPEUTICS
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ONCOCOLLAPSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 19, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 19, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 11, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 24, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 20, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 26, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 26, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 11, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 11, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 2, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 18, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 15, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 3, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 21, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |